| Year |
Citation |
Score |
| 2023 |
Gomez F, Fisk B, McMichael JF, Mosior M, Foltz JA, Skidmore ZL, Duncavage EJ, Miller CA, Abel H, Lee YS, Krysiak K, Russler-Germain DA, Watkins MP, Ramirez CA, Schmidt A, ... ... Griffith M, et al. Ultra-Deep Sequencing Reveals the Mutational Landscape of Classical Hodgkin Lymphoma. Cancer Research Communications. PMID 37910143 DOI: 10.1158/2767-9764.CRC-23-0140 |
0.352 |
|
| 2023 |
Cotto KC, Feng YY, Ramu A, Richters M, Freshour SL, Skidmore ZL, Xia H, McMichael JF, Kunisaki J, Campbell KM, Chen TH, Rozycki EB, Adkins D, Devarakonda S, Sankararaman S, ... ... Griffith M, et al. Integrated analysis of genomic and transcriptomic data for the discovery of splice-associated variants in cancer. Nature Communications. 14: 1589. PMID 36949070 DOI: 10.1038/s41467-023-37266-6 |
0.33 |
|
| 2021 |
Chu S, Skidmore ZL, Kunisaki J, Walker JR, Griffith M, Griffith OL, Bryan JN. Unraveling the chaotic genomic landscape of primary and metastatic canine appendicular osteosarcoma with current sequencing technologies and bioinformatic approaches. Plos One. 16: e0246443. PMID 33556121 DOI: 10.1371/journal.pone.0246443 |
0.302 |
|
| 2021 |
Uppaluri R, Campbell KM, Egloff AM, Zolkind P, Skidmore ZL, Nussenbaum B, Paniello RC, Rich JT, Jackson R, Pipkorn P, Michel LS, Ley J, Oppelt P, Dunn GP, Barnell EK, ... ... Griffith M, et al. Correction: Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-unrelated Head and Neck Cancer: A Multicenter, Phase II Trial. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 27: 357. PMID 33397681 DOI: 10.1158/1078-0432.CCR-20-4484 |
0.42 |
|
| 2020 |
Uppaluri R, Campbell KM, Egloff AM, Zolkind P, Skidmore ZL, Nussenbaum B, Paniello RC, Rich JT, Jackson R, Pipkorn P, Michel LS, Ley J, Oppelt P, Dunn GP, Barnell EK, ... ... Griffith M, et al. Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-Unrelated Head and Neck Cancer: A Multicenter, Phase 2 Trial. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32665297 DOI: 10.1158/1078-0432.Ccr-20-1695 |
0.49 |
|
| 2020 |
De Mattos-Arruda L, Vazquez M, Finotello F, Lepore R, Porta E, Hundal J, Amengual-Rigo P, Ng CKY, Valencia A, Carrillo J, Chan TA, Guallar V, McGranahan N, Blanco J, Griffith M. Neoantigen prediction and computational perspectives towards clinical benefit: Recommendations from the ESMO Precision Medicine Working Group. Annals of Oncology : Official Journal of the European Society For Medical Oncology. PMID 32610166 DOI: 10.1016/J.Annonc.2020.05.008 |
0.367 |
|
| 2020 |
Dang HX, Krasnick BA, White BS, Grossman JG, Strand MS, Zhang J, Cabanski CR, Miller CA, Fulton RS, Goedegebuure SP, Fronick CC, Griffith M, Larson DE, Goetz BD, Walker JR, et al. The clonal evolution of metastatic colorectal cancer. Science Advances. 6: eaay9691. PMID 32577507 DOI: 10.1126/Sciadv.Aay9691 |
0.368 |
|
| 2020 |
Wagner AH, Walsh B, Mayfield G, Tamborero D, Sonkin D, Krysiak K, Deu-Pons J, Duren RP, Gao J, McMurry J, Patterson S, Del Vecchio Fitz C, Pitel BA, Sezerman OU, Ellrott K, ... ... Griffith M, et al. A harmonized meta-knowledgebase of clinical interpretations of somatic genomic variants in cancer. Nature Genetics. PMID 32246132 DOI: 10.1038/S41588-020-0603-8 |
0.356 |
|
| 2020 |
Ramirez C, Frenkel F, Plotnikova O, Belousov V, Bagaev A, Ocheredko E, Kiwala S, Hundal J, Skidmore ZL, Watkins M, Becker-Hapak M, Fronick C, Fulton R, Schreiber R, Bartlett NL, ... ... Griffith M, et al. Identification of predicted neoantigen vaccine candidates in follicular lymphoma patients. Journal of Clinical Oncology. 38: 8054-8054. DOI: 10.1200/Jco.2020.38.15_Suppl.8054 |
0.344 |
|
| 2020 |
Church AJ, Rao S, Ritter D, Danos A, Krysiak K, Corson LB, Fisher KE, Hiemenz M, Janeway KA, Ji J, Kesserwan CA, Laetsch TW, Parsons DW, Schmidt RJ, Sund KL, ... ... Griffith M, et al. Abstract A58: Curation of pediatric cancer variants within the Clinical Genome Resource (ClinGen) Cancer Research. 80. DOI: 10.1158/1538-7445.Pedca19-A58 |
0.371 |
|
| 2020 |
Horak P, Griffith M, Danos A, Pitel BA, Madhavan S, Liu X, Lee J, Raca G, Li S, Wagner AH, Kulkarni S, Griffith OL, Chakravarty D, Sonkin D. Abstract 5707: A standard operating procedure for the interpretation of oncogenicity/pathogenicity of somatic mutations Cancer Research. 80: 5707-5707. DOI: 10.1158/1538-7445.Am2020-5707 |
0.363 |
|
| 2020 |
Pitel BA, Rao S, Fitz CDV, Madhavan S, Dientsmann R, Horak P, King I, Mockus SM, Raca G, Rieke DT, Rogan P, Sonkin D, Tamborero D, Vlachos IS, Walsh B, ... ... Griffith M, et al. Abstract 3222: The Virtual Molecular Tumor Board of the Variant Interpretation for Cancer Consortium: A systematic gateway connecting cancer genome interpretation and progress in genomic knowledgebases in cancer Cancer Research. 80: 3222-3222. DOI: 10.1158/1538-7445.Am2020-3222 |
0.376 |
|
| 2020 |
Wagner AH, Hart RK, Babb L, Freimuth RR, Coffman A, Liang Y, Pitel B, Roy A, Brush M, Lee J, Lu A, Coard T, Rao S, Ritter D, Walsh B, ... ... Griffith M, et al. Abstract 1096: Harmonization standards from the Variant Interpretation for Cancer Consortium Cancer Research. 80: 1096-1096. DOI: 10.1158/1538-7445.Am2020-1096 |
0.43 |
|
| 2020 |
Xia H, Richters M, Ramirez C, Saus CP, Cotto K, Dunn G, Fehniger T, Ribas A, Gillanders W, Griffith O, Griffith M. 65. Accurate neoantigen prediction depends on mutation position relative to patient-specific MHC anchor locations Cancer Genetics and Cytogenetics. 244: 24-25. DOI: 10.1016/J.Cancergen.2020.04.069 |
0.302 |
|
| 2020 |
Wagner A, Babb L, Freimuth R, Pitel B, Krysiak K, Roy A, Coard T, Lu A, King I, Sonkin D, Lee J, Raca G, Griffith M, Griffith O, Hart R. 59. Integrating cytogenomic and sequence variants in the GA4GH variation representation specification Cancer Genetics. 244: 22-23. DOI: 10.1016/J.Cancergen.2020.04.063 |
0.321 |
|
| 2020 |
Rao S, Ritter D, Danos A, Raca G, Roy A, Krysiak K, Lin W, Barnell E, McCoy M, Pitel B, Sonkin D, Wang J, Hosseini SA, Selvarajah S, King I, ... ... Griffith M, et al. 46. ClinGen somatic cancer working group: Enhancing standardized interpretation of cancer genetic data for clinical use Cancer Genetics. 244: 17-18. DOI: 10.1016/J.Cancergen.2020.04.050 |
0.307 |
|
| 2020 |
Lin W, Roy A, Church A, Rao S, Ritter D, Danos A, Krysiak K, Corson L, Fisher K, Williams H, Hiemenz M, Janeway K, Ji J, Kesserwan C, Laetsch T, ... ... Griffith M, et al. 30. Curation of genetic variants in childhood cancers within the Clinical Genome Resource (ClinGen) Cancer Genetics. 244: 11-12. DOI: 10.1016/J.Cancergen.2020.04.034 |
0.333 |
|
| 2020 |
Danos A, Krysiak K, Saliba J, Guerra J, Wagner A, McMichael J, Kiwala S, Coffman A, Barnell E, Spies N, Sheta L, Pema S, Kujan L, Clark K, Griffith M, et al. 9. Expansion of the CIViC data model for functional annotation of cancer variants Cancer Genetics. 244: 4. DOI: 10.1016/J.Cancergen.2020.04.013 |
0.315 |
|
| 2020 |
Cotto K, Feng Y, Skidmore Z, Ramu A, Kunisaki J, Conrad D, Lin Y, Chapman W, Uppaluri R, Govindan R, Griffith O, Griffith M. 8. Integrating genomic and transcriptomic data to identify splice altering mutations across 35 cancer types Cancer Genetics and Cytogenetics. 244: 3-4. DOI: 10.1016/J.Cancergen.2020.04.012 |
0.411 |
|
| 2019 |
Lever J, Jones MR, Danos AM, Krysiak K, Bonakdar M, Grewal JK, Culibrk L, Griffith OL, Griffith M, Jones SJM. Text-mining clinically relevant cancer biomarkers for curation into the CIViC database. Genome Medicine. 11: 78. PMID 31796060 DOI: 10.1186/S13073-019-0686-Y |
0.354 |
|
| 2019 |
Danos AM, Krysiak K, Barnell EK, Coffman AC, McMichael JF, Kiwala S, Spies NC, Sheta LM, Pema SP, Kujan L, Clark KA, Wollam AZ, Rao S, Ritter DI, Sonkin D, ... ... Griffith M, et al. Standard operating procedure for curation and clinical interpretation of variants in cancer. Genome Medicine. 11: 76. PMID 31779674 DOI: 10.1186/S13073-019-0687-X |
0.335 |
|
| 2019 |
Linette GP, Becker-Hapak M, Skidmore ZL, Baroja ML, Xu C, Hundal J, Spencer DH, Fu W, Cummins C, Robnett M, Kaabinejadian S, Hildebrand WH, Magrini V, Demeter R, Krupnick AS, ... ... Griffith M, et al. Immunological ignorance is an enabling feature of the oligo-clonal T cell response to melanoma neoantigens. Proceedings of the National Academy of Sciences of the United States of America. PMID 31685621 DOI: 10.1073/Pnas.1906026116 |
0.313 |
|
| 2019 |
Rauch DA, Conlon KC, Janakiram M, Brammer JE, Harding JC, Ye BH, Zang X, Ren X, Olson S, Cheng X, Miljkovic MD, Sundaramoorthi H, Joseph A, Skidmore ZL, Griffith O, ... Griffith M, et al. . Blood. PMID 31467059 DOI: 10.1182/Blood.2019002038 |
0.328 |
|
| 2019 |
Richters MM, Xia H, Campbell KM, Gillanders WE, Griffith OL, Griffith M. Best practices for bioinformatic characterization of neoantigens for clinical utility. Genome Medicine. 11: 56. PMID 31462330 DOI: 10.1186/S13073-019-0666-2 |
0.354 |
|
| 2019 |
Campbell KM, O'Leary KA, Rugowski DE, Mulligan WA, Barnell EK, Skidmore ZL, Krysiak K, Griffith M, Schuler LA, Griffith OL. A Spontaneous Aggressive ERα+ Mammary Tumor Model Is Driven by Kras Activation. Cell Reports. 28: 1526-1537.e4. PMID 31390566 DOI: 10.1016/J.Celrep.2019.06.098 |
0.368 |
|
| 2019 |
Hundal J, Kiwala S, Feng YY, Liu CJ, Govindan R, Chapman WC, Uppaluri R, Swamidass SJ, Griffith OL, Mardis ER, Griffith M. Accounting for proximal variants improves neoantigen prediction. Nature Genetics. 51: 175-179. PMID 30510237 DOI: 10.1038/S41588-018-0283-9 |
0.303 |
|
| 2019 |
Wagner AH, Griffith M, Griffith OL. Abstract 2478: Cancer genome interpretation with CIViCpy Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-2478 |
0.341 |
|
| 2019 |
Linette GP, Carreno BM, Skidmore ZL, Hundel J, Griffith OL, Griffith M, Magrini V, Mardis ER. Abstract 4949: Immunological ignorance is an enabling feature of the oligo-clonal T cell response to melanoma neoantigen Cancer Research. 79: 4949-4949. DOI: 10.1158/1538-7445.Am2019-4949 |
0.363 |
|
| 2019 |
Cotto KC, Feng Y, Skidmore ZL, Griffith OL, Griffith M. Abstract 2487: Application of RegTools to TCGA samples for the identification of tumor-specific splice variants Cancer Research. 79: 2487-2487. DOI: 10.1158/1538-7445.Am2019-2487 |
0.403 |
|
| 2019 |
Raca G, Rao S, Ritter D, Danos A, Krysiak K, Church AJ, Corson L, Fisher K, Hiemenz M, Janeway KA, Ji J, Kesserwan CA, Laetsch TW, Parsons DW, Schmidt R, ... ... Griffith M, et al. 34. Curation of variants associated with pediatric tumors within the Clinical Genome Resource (ClinGen) Cancer Genetics and Cytogenetics. DOI: 10.1016/J.Cancergen.2019.04.040 |
0.316 |
|
| 2019 |
Cotto K, Danos A, Lesurf R, Park M, Griffith M, Griffith O. 24. Identification of recurrent, non-coding mutations across breast cancer molecular subtypes Cancer Genetics and Cytogenetics. DOI: 10.1016/J.Cancergen.2019.04.030 |
0.35 |
|
| 2019 |
Gomez F, Skidmore Z, Schmidt A, Rodrigues-Martins F, Krysiak K, Ramirez C, Mosior M, Duncavage E, Triska G, Trani L, Bartlett N, Cashen A, Mehta-Shah N, Kahl B, Kreisel F, ... Griffith M, et al. 23. Ultra-deep sequencing of classical Hodgkin lymphoma (cHL) reveals novel somatic mutations and exemplifies the utility of deep sequencing in the characterization of rare malignant cells Cancer Genetics and Cytogenetics. DOI: 10.1016/J.Cancergen.2019.04.029 |
0.404 |
|
| 2018 |
Griffith OL, Spies NC, Anurag M, Griffith M, Luo J, Tu D, Yeo B, Kunisaki J, Miller CA, Krysiak K, Hundal J, Ainscough BJ, Skidmore ZL, Campbell K, Kumar R, et al. Author Correction: The prognostic effects of somatic mutations in ER-positive breast cancer. Nature Communications. 9: 4850. PMID 30429476 DOI: 10.1038/S41467-018-07407-3 |
0.303 |
|
| 2018 |
Ainscough BJ, Barnell EK, Ronning P, Campbell KM, Wagner AH, Fehniger TA, Dunn GP, Uppaluri R, Govindan R, Rohan TE, Griffith M, Mardis ER, Swamidass SJ, Griffith OL. A deep learning approach to automate refinement of somatic variant calling from cancer sequencing data. Nature Genetics. PMID 30397337 DOI: 10.1038/S41588-018-0257-Y |
0.379 |
|
| 2018 |
Danos AM, Ritter DI, Wagner AH, Krysiak K, Sonkin D, Micheel C, McCoy M, Rao S, Raca G, Boca SM, Roy A, Barnell EK, McMichael JF, Kiwala S, Coffman AC, ... ... Griffith M, et al. Adapting crowdsourced clinical cancer curation in CIViC to the ClinGen minimum variant level data community-driven standards. Human Mutation. 39: 1721-1732. PMID 30311370 DOI: 10.1002/Humu.23651 |
0.35 |
|
| 2018 |
Barnell EK, Ronning P, Campbell KM, Krysiak K, Ainscough BJ, Sheta LM, Pema SP, Schmidt AD, Richters M, Cotto KC, Danos AM, Ramirez C, Skidmore ZL, Spies NC, Hundal J, ... ... Griffith M, et al. Standard operating procedure for somatic variant refinement of sequencing data with paired tumor and normal samples. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 30287923 DOI: 10.1038/S41436-018-0278-Z |
0.354 |
|
| 2018 |
Wagner AH, Devarakonda S, Skidmore ZL, Krysiak K, Ramu A, Trani L, Kunisaki J, Masood A, Waqar SN, Spies NC, Morgensztern D, Waligorski J, Ponce J, Fulton RS, Maggi LB, ... ... Griffith M, et al. Recurrent WNT pathway alterations are frequent in relapsed small cell lung cancer. Nature Communications. 9: 3787. PMID 30224629 DOI: 10.1038/S41467-018-06162-9 |
0.366 |
|
| 2018 |
Griffith OL, Spies NC, Anurag M, Griffith M, Luo J, Tu D, Yeo B, Kunisaki J, Miller CA, Krysiak K, Hundal J, Ainscough BJ, Skidmore ZL, Campbell K, Kumar R, et al. The prognostic effects of somatic mutations in ER-positive breast cancer. Nature Communications. 9: 3476. PMID 30181556 DOI: 10.1038/S41467-018-05914-X |
0.4 |
|
| 2018 |
Campbell KM, Lin T, Zolkind P, Barnell EK, Skidmore ZL, Winkler AE, Law JH, Mardis ER, Wartman LD, Adkins DR, Chernock RD, Griffith M, Uppaluri R, Griffith OL. Oral Cavity Squamous Cell Carcinoma Xenografts Retain Complex Genotypes and Intertumor Molecular Heterogeneity. Cell Reports. 24: 2167-2178. PMID 30134176 DOI: 10.1016/J.Celrep.2018.07.058 |
0.378 |
|
| 2018 |
O'Leary KA, Campbell KM, Rugowski DE, Krysiak K, Mulligan WA, Griffith M, Griffith OL, Schuler LA. Abstract 5104: Prolactin-induced mammary tumors: A preclinical model of luminal B breast cancer which exhibits mutations in the RAS pathway Cancer Research. 78: 5104-5104. DOI: 10.1158/1538-7445.Am2018-5104 |
0.407 |
|
| 2018 |
Danos A, Ritter D, Krysiak K, Sonkin D, Micheel C, McCoy M, Rao S, Raca G, Boca S, Roy A, Sidiropoulos N, Aisner D, Leon A, Wagner A, Li XS, ... ... Griffith M, et al. 29. Integrating ClinGen somatic cancer variant description standards into crowdsourced curation technology via CIViC database for ClinVar submission Cancer Genetics and Cytogenetics. 47. DOI: 10.1016/J.Cancergen.2018.04.090 |
0.311 |
|
| 2018 |
Raca G, Ritter D, Micheel C, Sonkin D, McCoy M, McGarvey P, Rao S, Li M, Griffith M, Griffith O, Roy A, Kulkarni S, Madhavan S. 21. Cancer curation in the clinical genome resource (on behalf of the ClinGen Somatic Working Group) Cancer Genetics and Cytogenetics. 44. DOI: 10.1016/J.Cancergen.2018.04.082 |
0.329 |
|
| 2018 |
Wagner A, Walsh B, Sonkin D, Dienstmann R, Li XS, Beckmann JS, Mayfield G, Tamborero D, Lopez-Bigas N, Goecks J, Margolin A, Griffith M, Griffith O. 4. Coordinating variant interpretation knowledgebases improves clinical interpretation of genomic variants in cancers Cancer Genetics and Cytogenetics. 37. DOI: 10.1016/J.Cancergen.2018.04.065 |
0.351 |
|
| 2017 |
Bartlett NL, Costello BA, LaPlant BR, Ansell SM, Kuruvilla JG, Reeder CB, Thye LS, Anderson DM, Krysiak K, Ramirez C, Qi J, Siegel BA, Griffith M, Griffith OL, Gomez F, et al. Single-Agent Ibrutinib in Relapsed or Refractory Follicular Lymphoma: A Phase 2 Consortium Trial. Blood. PMID 29074501 DOI: 10.1182/Blood-2017-09-804641 |
0.325 |
|
| 2017 |
Feng YY, Griffith OL, Griffith M. Clinical implications of neoepitope landscapes for adult and pediatric cancers. Genome Medicine. 9: 77. PMID 28854952 DOI: 10.1186/S13073-017-0470-9 |
0.378 |
|
| 2017 |
Lesurf R, Griffith OL, Griffith M, Hundal J, Trani L, Watson MA, Aft R, Ellis MJ, Ota D, Suman VJ, Meric-Bernstam F, Leitch AM, Boughey JC, Unzeitig G, Buzdar AU, et al. Genomic characterization of HER2-positive breast cancer and response to neoadjuvant trastuzumab and chemotherapy-results from the ACOSOG Z1041 (Alliance) trial. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 28: 1070-1077. PMID 28453704 DOI: 10.1093/Annonc/Mdx048 |
0.341 |
|
| 2017 |
Whyte MP, Griffith M, Trani L, Mumm S, Gottesman GS, McAlister WH, Krysiak K, Lesurf R, Skidmore ZL, Campbell KM, Rosman IS, Bayliss S, Bijanki VN, Nenninger A, Van Tine BA, et al. Melorheostosis: Exome sequencing of an associated dermatosis implicates postzygotic mosaicism of mutated KRAS. Bone. PMID 28434888 DOI: 10.1016/J.Bone.2017.04.010 |
0.36 |
|
| 2017 |
Hundal J, Miller CA, Griffith M, Griffith OL, Walker J, Kiwala S, Graubert A, McMichael J, Coffman A, Mardis ER. Cancer Immunogenomics: Computational Neoantigen Identification and Vaccine Design. Cold Spring Harbor Symposia On Quantitative Biology. PMID 28389595 DOI: 10.1101/Sqb.2016.81.030726 |
0.363 |
|
| 2017 |
Griffith M, Spies NC, Krysiak K, McMichael JF, Coffman AC, Danos AM, Ainscough BJ, Ramirez CA, Rieke DT, Kujan L, Barnell EK, Wagner AH, Skidmore ZL, Wollam A, Liu CJ, et al. CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer. Nature Genetics. 49: 170-174. PMID 28138153 DOI: 10.1038/Ng.3774 |
0.334 |
|
| 2017 |
Griffith O, Griffith M, Tamborero D, Wagner A, Krysiak K, Fitz CDV, Chakravarty D, Cerami E, Elemento O, Schultz N, Margolin A, Lopez-Bigas N. Global integration of knowledgebases for clinical interpretation of cancer variants F1000research. 6. DOI: 10.7490/F1000Research.1113918.1 |
0.308 |
|
| 2017 |
Gomez F, Krysiak K, Ramirez C, Duncavage EJ, Skidmore Z, Triska G, Trani L, Bartlett NL, Cashen AF, Mehta-Shah N, Kahl BS, Kreisel F, Griffith M, Fehniger TA, Griffith O. Ultra Deep Whole Exome Sequencing of Classical Hodgkin Lymphoma (cHL) Reveals Novel Recurrent Somatic Mutations Blood. 130: 2733-2733. DOI: 10.1182/Blood.V130.Suppl_1.2733.2733 |
0.395 |
|
| 2017 |
Zolkind PA, Campbell KM, Lin T, Skidmore Z, Winkler A, Barnell E, Giri T, Adkins DR, Griffith M, Dunn GP, Griffith OL, Uppaluri R. Abstract PR01: Genomic and functional correlates from a phase II clinical trial of trametinib in surgically resectable oral cavity squamous cell carcinoma Clinical Cancer Research. 23. DOI: 10.1158/1557-3265.Aacrahns17-Pr01 |
0.378 |
|
| 2017 |
Campbell KM, Lin T, Winkler AE, Zolkind P, Skidmore ZL, Barnell EK, Hagemann I, Mardis ER, Griffith M, Chernock RD, Griffith OL, Uppaluri R. Abstract 3847: Oral cavity squamous cell carcinoma xenografts display conservation of primary tumor genomic heterogeneity Cancer Research. 77: 3847-3847. DOI: 10.1158/1538-7445.Am2017-3847 |
0.3 |
|
| 2017 |
Griffith OL, Griffith M, Tamborero D, Wagner AH, Krysiak K, Fitz CDV, Chakravarty D, Cerami E, Elemento O, Schultz N, Margolin A, Lopez-Bigas N. Abstract 2608: Global integration of knowledgebases for clinical interpretation of cancer variants Cancer Research. 77: 2608-2608. DOI: 10.1158/1538-7445.Am2017-2608 |
0.308 |
|
| 2017 |
Gomez F, Krysiak K, Ramirez C, Bartlett N, Cashen A, Kreisel F, Duncavage E, Griffith M, Fehniger T, Griffith O. Abstract 2448: Deep exome sequencing reveals recurrent somatic mutations in Hodgkin's lymphoma Cancer Research. 77: 2448-2448. DOI: 10.1158/1538-7445.Am2017-2448 |
0.379 |
|
| 2017 |
Krysiak K, Ramirez C, Gomez F, Miller CA, Fulton RS, Kreisel F, Cashen AF, Bartlett NL, Ruano A, Hsi ED, Griffith M, Griffith OL, Fehniger TA. Abstract 2444: Recurrent mutations and clinical outcomes in patients with follicular lymphoma Cancer Research. 77: 2444-2444. DOI: 10.1158/1538-7445.Am2017-2444 |
0.303 |
|
| 2016 |
Krysiak K, Gomez F, White BS, Matlock M, Miller CA, Trani L, Fronick CC, Fulton RS, Kreisel F, Cashen AF, Carson KR, Berrien-Elliott MM, Bartlett NL, Griffith M, Griffith OL, et al. Recurrent somatic mutations affecting B-cell receptor signaling pathway genes in follicular lymphoma. Blood. PMID 28064239 DOI: 10.1182/Blood-2016-07-729954 |
0.415 |
|
| 2016 |
Zolkind P, Dunn GP, Lin T, Griffith M, Griffith OL, Uppaluri R. Neoantigens in immunotherapy and personalized vaccines: Implications for head and neck squamous cell carcinoma. Oral Oncology. PMID 27751760 DOI: 10.1016/J.Oraloncology.2016.09.010 |
0.338 |
|
| 2016 |
Ainscough BJ, Griffith M, Coffman AC, Wagner AH, Kunisaki J, Choudhary MN, McMichael JF, Fulton RS, Wilson RK, Griffith OL, Mardis ER. DoCM: a database of curated mutations in cancer. Nature Methods. 13: 806-7. PMID 27684579 DOI: 10.1038/Nmeth.4000 |
0.376 |
|
| 2016 |
Griffith OL, Chan SR, Griffith M, Krysiak K, Skidmore ZL, Hundal J, Allen JA, Arthur CD, Runci D, Bugatti M, Miceli AP, Schmidt H, Trani L, Kanchi KL, Miller CA, et al. Truncating Prolactin Receptor Mutations Promote Tumor Growth in Murine Estrogen Receptor-Alpha Mammary Carcinomas. Cell Reports. 17: 249-60. PMID 27681435 DOI: 10.1016/J.Celrep.2016.08.076 |
0.385 |
|
| 2016 |
Miller CA, Gindin Y, Lu C, Griffith OL, Griffith M, Shen D, Hoog J, Li T, Larson DE, Watson M, Davies SR, Hunt K, Suman VJ, Snider J, Walsh T, et al. Aromatase inhibition remodels the clonal architecture of estrogen-receptor-positive breast cancers. Nature Communications. 7: 12498. PMID 27502118 DOI: 10.1038/Ncomms12498 |
0.405 |
|
| 2016 |
Griffith M, Griffith OL, Krysiak K, Skidmore ZL, Christopher MJ, Klco JM, Ramu A, Lamprecht TL, Wagner AH, Campbell KM, Lesurf R, Hundal J, Zhang J, Spies NC, Ainscough BJ, et al. Comprehensive genomic analysis reveals FLT3 activation and a therapeutic strategy for a patient with relapsed adult B lymphoblastic leukemia. Experimental Hematology. PMID 27181063 DOI: 10.1016/J.Exphem.2016.04.011 |
0.397 |
|
| 2016 |
Lu C, Riedell P, Miller CA, Hagemann IS, Westervelt P, Ozenberger BA, O'Laughlin M, Magrini V, Demeter RT, Duncavage EJ, Griffith M, Griffith OL, Wartman LD. A common founding clone with TP53 and PTEN mutations gives rise to a concurrent germ cell tumor and acute megakaryoblastic leukemia. Cold Spring Harbor Molecular Case Studies. 2: a000687. PMID 27148581 DOI: 10.1101/mcs.a000687 |
0.311 |
|
| 2016 |
Hundal J, Carreno BM, Petti AA, Linette GP, Griffith OL, Mardis ER, Griffith M. pVAC-Seq: A genome-guided in silico approach to identifying tumor neoantigens. Genome Medicine. 8: 11. PMID 26825632 DOI: 10.1186/S13073-016-0264-5 |
0.416 |
|
| 2016 |
Oh ST, Miller CA, Gindin Y, Brost TM, Chan J, Fulbright MC, Fisher DA, Duncavage EJ, O'Laughlin M, Griffith M, Griffith OL, Wartman LD. Clonal Evolution Revealed By Exome Sequencing in a Case of Primary Myelofibrosis Associated with Subsequent Development of Aggressive Systemic Mastocytosis/Mast Cell Leukemia Blood. 128: 5496-5496. DOI: 10.1182/Blood.V128.22.5496.5496 |
0.356 |
|
| 2016 |
Gomez F, Matlock M, Krysiak K, Lee Y, Duncavage EJ, O'Laughlin M, Griffith M, Fehniger TA, Wartman LD, Griffith OL. Exome Sequencing of Hodgkin's and Non-Hodgkin Composite Lymphomas Identifies Shared Somatic Mutations Indicative of Common Founding Precursors Blood. 128: 5285-5285. DOI: 10.1182/Blood.V128.22.5285.5285 |
0.382 |
|
| 2016 |
Krysiak K, Jacoby MA, Skidmore ZL, Danos AM, O'Laughlin M, Duncavage EJ, Walter MJ, Griffith M, Griffith OL, Wartman LD. Deleterious Germline Mutations in Telomere Maintenance Genes Identified in a Subset of Patients with Myelodysplastic Syndrome and Idiopathic Pulmonary Fibrosis Blood. 128: 4306-4306. DOI: 10.1182/Blood.V128.22.4306.4306 |
0.424 |
|
| 2016 |
Mardis E, Griffith OL, Szeman RC, Griffith M, Krysiak K, Skidmore Z, Hundal J, Allen JA, Cora A, Miceli AP, Schmidt H, Trani L, Kanchi K, Miller CA, Larson DE, et al. Abstract IA20: Genomics of a STAT1 knockout mouse model of human ER+ breast cancer Molecular Cancer Research. 14. DOI: 10.1158/1557-3125.Advbc15-Ia20 |
0.391 |
|
| 2016 |
Lesurf R, Griffith O, Griffith M, Watson M, Hoog J, Ellis M, Ota D, Suman V, Meric-Bernstam F, Leitch A, Boughey J, Unzeitig G, Buzdar A, Hunt K, Mardis E. Abstract PD6-02: The genomics of response to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer – Results from the ACOSOG Z1041 (Alliance) trial Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-Pd6-02 |
0.403 |
|
| 2016 |
Krysiak K, Gomez F, White BS, Matlock M, Miller CA, Fulton RS, Kreisel F, Cashen AF, Carson KR, Berrien-Elliott MM, Bartlett NL, Wilson RK, Mardis ER, Griffith M, Griffith OL, et al. Abstract LB-326: Identification of novel recurrent mutations in follicular lymphoma Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Lb-326 |
0.428 |
|
| 2016 |
Hundal J, Carreno BM, Petti AA, Linette GP, Griffith OL, Griffith M, Mardis ER. Abstract 3995: pVAC-Seq: A genome-guidedin silicoapproach to identify tumor neoantigens for personalized immunotherapy Cancer Research. 76: 3995-3995. DOI: 10.1158/1538-7445.Am2016-3995 |
0.405 |
|
| 2015 |
Griffith M, Miller CA, Griffith OL, Krysiak K, Skidmore ZL, Ramu A, Walker JR, Dang HX, Trani L, Larson DE, Demeter RT, Wendl MC, McMichael JF, Austin RE, Magrini V, et al. Optimizing cancer genome sequencing and analysis. Cell Systems. 1: 210-223. PMID 26645048 DOI: 10.7490/F1000Research.1110088.1 |
0.379 |
|
| 2015 |
Griffith M, Walker JR, Spies NC, Ainscough BJ, Griffith OL. Informatics for RNA Sequencing: A Web Resource for Analysis on the Cloud. Plos Computational Biology. 11: e1004393. PMID 26248053 DOI: 10.1371/Journal.Pcbi.1004393 |
0.319 |
|
| 2015 |
Griffith M, Griffith OL, Smith SM, Ramu A, Callaway MB, Brummett AM, Kiwala MJ, Coffman AC, Regier AA, Oberkfell BJ, Sanderson GE, Mooney TP, Nutter NG, Belter EA, Du F, et al. Genome Modeling System: A Knowledge Management Platform for Genomics. Plos Computational Biology. 11: e1004274. PMID 26158448 DOI: 10.1371/Journal.Pcbi.1004274 |
0.344 |
|
| 2015 |
Shirai CL, Ley JN, White BS, Kim S, Tibbitts J, Shao J, Ndonwi M, Wadugu B, Duncavage EJ, Okeyo-Owuor T, Liu T, Griffith M, McGrath S, Magrini V, Fulton RS, et al. Mutant U2AF1 Expression Alters Hematopoiesis and Pre-mRNA Splicing In Vivo. Cancer Cell. 27: 631-43. PMID 25965570 DOI: 10.1016/J.Ccell.2015.04.008 |
0.389 |
|
| 2015 |
Gascard P, Bilenky M, Sigaroudinia M, Zhao J, Li L, Carles A, Delaney A, Tam A, Kamoh B, Cho S, Griffith M, Chu A, Robertson G, Cheung D, Li I, et al. Epigenetic and transcriptional determinants of the human breast. Nature Communications. 6: 6351. PMID 25690954 DOI: 10.1038/Ncomms7351 |
0.481 |
|
| 2015 |
Juric D, Castel P, Griffith M, Griffith OL, Won HH, Ellis H, Ebbesen SH, Ainscough BJ, Ramu A, Iyer G, Shah RH, Huynh T, Mino-Kenudson M, Sgroi D, Isakoff S, et al. Convergent loss of PTEN leads to clinical resistance to a PI(3)Kα inhibitor. Nature. 518: 240-4. PMID 25409150 DOI: 10.1038/Nature13948 |
0.376 |
|
| 2015 |
Okeyo-Owuor T, White BS, Chatrikhi R, Mohan DR, Kim S, Griffith M, Ding L, Ketkar-Kulkarni S, Hundal J, Laird KM, Kielkopf CL, Ley TJ, Walter MJ, Graubert TA. U2AF1 mutations alter sequence specificity of pre-mRNA binding and splicing. Leukemia. 29: 909-17. PMID 25311244 DOI: 10.1038/Leu.2014.303 |
0.383 |
|
| 2015 |
Griffith M. Optimizing tumor genome sequencing and analysis F1000research. 4. DOI: 10.7490/F1000Research.1110086.1 |
0.338 |
|
| 2015 |
Griffith M, Spies N, Krysiak K, McMichael J, Coffman A, Ainscough B, Bilski R, Eldred J, Larson D, Walker J, Wilson R, Mardis E, Griffith O. CIViC: Crowdsourcing the Clinical Interpretation of Variants in Cancer F1000research. 4. DOI: 10.7490/F1000Research.1110019.1 |
0.315 |
|
| 2015 |
Fehniger TA, Krysiak K, White BS, Matlock M, Miller C, Fulton R, Kreisel F, Fronick C, Cook L, Veizer J, Cashen AF, Carson KR, Berrien-Elliott MM, Bartlett NL, Wilson RK, ... ... Griffith M, et al. Recurrent Somatic Genomic Alterations in Follicular NHL (FL) Revealed By Exome and Custom-Capture Next Generation Sequencing Blood. 126: 574-574. DOI: 10.1182/Blood.V126.23.574.574 |
0.416 |
|
| 2015 |
Klco JM, Miller CA, Griffith M, Petti A, Spencer DH, Ketkar-Kulkarni S, Wartman LD, Christopher M, Lamprecht TL, Payton JE, Baty J, Heath SE, Griffith OL, Shen D, Hundal J, et al. Abstract PR11: Genomic approaches for risk assessment in acute myeloid leukemia Cancer Research. 75. DOI: 10.1158/1538-7445.Transcagen-Pr11 |
0.363 |
|
| 2015 |
Ainscough BJ, Griffith M, Kunisaki J, Coffman A, McMichael JF, Eldred JM, Walker JR, Fulton RS, Wilson RK, Griffith OL, Mardis ER. Abstract PR01: Identifying clinically important somatic mutations through a knowledge-based approach Cancer Research. 75. DOI: 10.1158/1538-7445.Transcagen-Pr01 |
0.454 |
|
| 2015 |
Griffith M, Griffith O, Spies N, Ainscough B, Skidmore Z, Trani L, Ramu A, Krysiak K, Mardis ER. Abstract IA02: Cancer genomics: Translational challenges Cancer Research. 75. DOI: 10.1158/1538-7445.Transcagen-Ia02 |
0.374 |
|
| 2015 |
Griffith M, Griffith OL, Ramu A, Ainscough JB, Krysiak K, Choudhary M, Skidmore Z, Tan B, Ramaswamy G, Tine BV, Ellis MJ, Ley TJ, Wilson RK, Mardis ER. Abstract A1-44: Clinical cancer sequencing and integrated analysis of whole genomes, exomes and transcriptomes Cancer Research. 75. DOI: 10.1158/1538-7445.Transcagen-A1-44 |
0.36 |
|
| 2015 |
Miller CA, Griffith M, Ramu A, Skidmore ZL, Griffith OL, Magrini V, Demeter R, Dang H, Walker J, Larson DE, Fulton RS, Maher C, Mardis ER, Ley TJ, Wilson RK. Abstract A1-13: Ultra-deep whole-genome sequencing reveals clinically relevant low-frequency subclones in an acute myeloid leukemia Cancer Research. 75. DOI: 10.1158/1538-7445.Transcagen-A1-13 |
0.433 |
|
| 2015 |
Griffith OL, Griffith M, Spies NC, Luo J, Hundal J, Miller CA, Larson DE, Fulton R, Liu S, Leung S, Wilson RK, Nielsen TO, Mardis ER, Ellis MJ. Abstract A1-06: Recurrent mutations of hormone-positive breast cancer and association with outcome Cancer Research. 75. DOI: 10.1158/1538-7445.Transcagen-A1-06 |
0.444 |
|
| 2015 |
Griffith OL, Griffith M, Luo J, Hundall J, Miller CA, Larson DE, Fulton R, Wilson RK, Liu S, Leung S, Nielsen TO, Mardis ER, Ellis MJ. Abstract S1-02: Prognostic effects of gene mutation in estrogen receptor positive breast cancer Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-S1-02 |
0.435 |
|
| 2015 |
Klco JM, Miller CA, Griffith M, Petti A, Spencer DH, Ketkar-Kulkarni S, Wartman LD, Christopher M, Lamprecht TL, Payton JE, Baty J, Heath SE, Griffith OL, Shen D, Hundal J, et al. Abstract PR03: Genomic approaches for risk assessment in acute myeloid leukemia Cancer Research. 75. DOI: 10.1158/1538-7445.Compsysbio-Pr03 |
0.367 |
|
| 2015 |
Dang HX, Grossman J, White BS, Strand M, Larson DE, Walker J, Pittman E, Fleming T, Goedegebuure PS, Fulton RS, Miller CA, Griffith M, Lim KH, Ley TJ, Wilson RK, et al. Abstract 4109: Clonal evolution of metastatic colorectal cancer Cancer Research. 75: 4109-4109. DOI: 10.1158/1538-7445.Am2015-4109 |
0.305 |
|
| 2014 |
Ding L, Kim M, Kanchi KL, Dees ND, Lu C, Griffith M, Fenstermacher D, Sung H, Miller CA, Goetz B, Wendl MC, Griffith O, Cornelius LA, Linette GP, McMichael JF, et al. Clonal architectures and driver mutations in metastatic melanomas. Plos One. 9: e111153. PMID 25393105 DOI: 10.1371/Journal.Pone.0111153 |
0.438 |
|
| 2014 |
Alder O, Cullum R, Lee S, Kan AC, Wei W, Yi Y, Garside VC, Bilenky M, Griffith M, Morrissy AS, Robertson GA, Thiessen N, Zhao Y, Chen Q, Pan D, et al. Hippo signaling influences HNF4A and FOXA2 enhancer switching during hepatocyte differentiation. Cell Reports. 9: 261-71. PMID 25263553 DOI: 10.1016/J.Celrep.2014.08.046 |
0.451 |
|
| 2014 |
Miller CA, White BS, Dees ND, Griffith M, Welch JS, Griffith OL, Vij R, Tomasson MH, Graubert TA, Walter MJ, Ellis MJ, Schierding W, DiPersio JF, Ley TJ, Mardis ER, et al. SciClone: inferring clonal architecture and tracking the spatial and temporal patterns of tumor evolution. Plos Computational Biology. 10: e1003665. PMID 25102416 DOI: 10.1371/Journal.Pcbi.1003665 |
0.382 |
|
| 2014 |
Cabanski CR, Magrini V, Griffith M, Griffith OL, McGrath S, Zhang J, Walker J, Ly A, Demeter R, Fulton RS, Pong WW, Gutmann DH, Govindan R, Mardis ER, Maher CA. cDNA hybrid capture improves transcriptome analysis on low-input and archived samples. The Journal of Molecular Diagnostics : Jmd. 16: 440-51. PMID 24814956 DOI: 10.1016/J.Jmoldx.2014.03.004 |
0.357 |
|
| 2014 |
Klco JM, Spencer DH, Miller CA, Griffith M, Lamprecht TL, O'Laughlin M, Fronick C, Magrini V, Demeter RT, Fulton RS, Eades WC, Link DC, Graubert TA, Walter MJ, Mardis ER, et al. Functional heterogeneity of genetically defined subclones in acute myeloid leukemia. Cancer Cell. 25: 379-92. PMID 24613412 DOI: 10.1016/J.Ccr.2014.01.031 |
0.342 |
|
| 2014 |
Tucker T, Zahir FR, Griffith M, Delaney A, Chai D, Tsang E, Lemyre E, Dobrzeniecka S, Marra M, Eydoux P, Langlois S, Hamdan FF, Michaud JL, Friedman JM. Single exon-resolution targeted chromosomal microarray analysis of known and candidate intellectual disability genes. European Journal of Human Genetics : Ejhg. 22: 792-800. PMID 24253858 DOI: 10.1038/Ejhg.2013.248 |
0.49 |
|
| 2014 |
Castel P, Juric D, Won H, Ainscough B, Ellis H, Ebbesen S, Griffith M, Griffith O, Gopakumar I, Sgroi D, Isakoff S, Mardis E, Solit D, Lowe S, Quadt C, et al. Abstract LB-327: Loss of PTEN leads to clinical resistance to the PI3Kα inhibitor BYL719 and provides evidence of convergent evolution under selective therapeutic pressure Cancer Research. 74. DOI: 10.1158/1538-7445.Am2014-Lb-327 |
0.408 |
|
| 2014 |
Griffith OL, Lin Y, Griffith M, Hundal J, Regier A, Fulton R, Brunt EM, Wilson RK, Chapman W, Mardis ER. Abstract 5181: Genomic and transcriptomic somatic alterations of hepatocellular carcinoma in non-cirrhotic livers Cancer Research. 74: 5181-5181. DOI: 10.1158/1538-7445.Am2014-5181 |
0.355 |
|
| 2014 |
Griffith OL, Griffith M. VEGA (Vertebrate Genome Annotation Database) Dictionary of Bioinformatics and Computational Biology. DOI: 10.1002/9780471650126.Dob1126 |
0.307 |
|
| 2014 |
Griffith M, Griffith OL. Mitelman Database (Chromosome Aberrations and Gene Fusions in Cancer) Dictionary of Bioinformatics and Computational Biology. DOI: 10.1002/9780471650126.Dob0996 |
0.309 |
|
| 2014 |
Griffith M, Griffith OL. Cancer Gene Census (CGC) Dictionary of Bioinformatics and Computational Biology. DOI: 10.1002/9780471650126.Dob0833 |
0.332 |
|
| 2013 |
Daemen A, Griffith OL, Heiser LM, Wang NJ, Enache OM, Sanborn Z, Pepin F, Durinck S, Korkola JE, Griffith M, Hur JS, Huh N, Chung J, Cope L, Fackler MJ, et al. Modeling precision treatment of breast cancer. Genome Biology. 14: R110. PMID 24176112 DOI: 10.1186/Gb-2013-14-10-R110 |
0.313 |
|
| 2013 |
Griffith M, Griffith OL, Coffman AC, Weible JV, McMichael JF, Spies NC, Koval J, Das I, Callaway MB, Eldred JM, Miller CA, Subramanian J, Govindan R, Kumar RD, Bose R, et al. DGIdb: mining the druggable genome. Nature Methods. 10: 1209-10. PMID 24122041 DOI: 10.1038/Nmeth.2689 |
0.324 |
|
| 2013 |
Griffith M, Mwenifumbo JC, Cheung PY, Paul JE, Pugh TJ, Tang MJ, Chittaranjan S, Morin RD, Asano JK, Ally AA, Miao L, Lee A, Chan SY, Taylor G, Severson T, et al. Novel mRNA isoforms and mutations of uridine monophosphate synthetase and 5-fluorouracil resistance in colorectal cancer. The Pharmacogenomics Journal. 13: 148-58. PMID 22249354 DOI: 10.1038/Tpj.2011.65 |
0.724 |
|
| 2013 |
Okeyo-Owuor T, White BS, Mohan D, Griffith M, Walter MJ, Graubert T. Allele-Specific Effects of U2AF1 Mutations on Alternative Splicing Blood. 122: 2748-2748. DOI: 10.1182/Blood.V122.21.2748.2748 |
0.389 |
|
| 2013 |
Kim M, Ding L, Dees N, Kanchi KL, Sung H, Fenstermacher D, Griffith M, Linette G, Cornelius L, Sondak VK, Mulé JJ, Wilson RK, Weber JS. Abstract 3170: Identification of novel genetic alterations driving melanoma tumorigenesis. Cancer Research. 73: 3170-3170. DOI: 10.1158/1538-7445.Am2013-3170 |
0.459 |
|
| 2012 |
Cheng SW, Kuzyk MA, Moradian A, Ichu TA, Chang VC, Tien JF, Vollett SE, Griffith M, Marra MA, Morin GB. Interaction of cyclin-dependent kinase 12/CrkRS with cyclin K1 is required for the phosphorylation of the C-terminal domain of RNA polymerase II. Molecular and Cellular Biology. 32: 4691-704. PMID 22988298 DOI: 10.1128/Mcb.06267-11 |
0.421 |
|
| 2012 |
Govindan R, Ding L, Griffith M, Subramanian J, Dees ND, Kanchi KL, Maher CA, Fulton R, Fulton L, Wallis J, Chen K, Walker J, McDonald S, Bose R, Ornitz D, et al. Genomic landscape of non-small cell lung cancer in smokers and never-smokers. Cell. 150: 1121-34. PMID 22980976 DOI: 10.1016/J.Cell.2012.08.024 |
0.421 |
|
| 2012 |
Shah SP, Roth A, Goya R, Oloumi A, Ha G, Zhao Y, Turashvili G, Ding J, Tse K, Haffari G, Bashashati A, Prentice LM, Khattra J, Burleigh A, Yap D, ... ... Griffith M, et al. The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature. 486: 395-9. PMID 22495314 DOI: 10.1038/Nature10933 |
0.786 |
|
| 2012 |
Ellis MJ, Li D, Shen D, Luo J, Suman VJ, Wallis JW, Tine BAV, Hoog J, Crowder RJ, Snider JE, Ballman K, Chen K, Koboldt DC, Schierding WS, McMichael JF, ... ... Griffith M, et al. Abstract LB-423: Whole genome comparisons of pre- and post- aromatase inhibitor treatment in estrogen receptor positive breast cancer Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Lb-423 |
0.402 |
|
| 2011 |
Morin RD, Mendez-Lago M, Mungall AJ, Goya R, Mungall KL, Corbett RD, Johnson NA, Severson TM, Chiu R, Field M, Jackman S, Krzywinski M, Scott DW, Trinh DL, Tamura-Wells J, ... ... Griffith M, et al. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma Nature. 476: 298-303. PMID 21796119 DOI: 10.1038/Nature10351 |
0.77 |
|
| 2011 |
Morrissy AS, Griffith M, Marra MA. Extensive relationship between antisense transcription and alternative splicing in the human genome. Genome Research. 21: 1203-12. PMID 21719572 DOI: 10.1101/Gr.113431.110 |
0.5 |
|
| 2011 |
McPherson A, Hormozdiari F, Zayed A, Giuliany R, Ha G, Sun MG, Griffith M, Heravi Moussavi A, Senz J, Melnyk N, Pacheco M, Marra MA, Hirst M, Nielsen TO, Sahinalp SC, et al. deFuse: an algorithm for gene fusion discovery in tumor RNA-Seq data. Plos Computational Biology. 7: e1001138. PMID 21625565 DOI: 10.1371/Journal.Pcbi.1001138 |
0.562 |
|
| 2010 |
Robertson G, Schein J, Chiu R, Corbett R, Field M, Jackman SD, Mungall K, Lee S, Okada HM, Qian JQ, Griffith M, Raymond A, Thiessen N, Cezard T, Butterfield YS, et al. De novo assembly and analysis of RNA-seq data. Nature Methods. 7: 909-12. PMID 20935650 DOI: 10.1038/Nmeth.1517 |
0.459 |
|
| 2010 |
Griffith M, Griffith OL, Mwenifumbo J, Goya R, Morrissy AS, Morin RD, Corbett R, Tang MJ, Hou YC, Pugh TJ, Robertson G, Chittaranjan S, Ally A, Asano JK, Chan SY, et al. Alternative expression analysis by RNA sequencing. Nature Methods. 7: 843-7. PMID 20835245 DOI: 10.1038/Nmeth.1503 |
0.765 |
|
| 2010 |
Jones SJ, Laskin J, Li YY, Griffith OL, An J, Bilenky M, Butterfield YS, Cezard T, Chuah E, Corbett R, Fejes AP, Griffith M, Yee J, Martin M, Mayo M, et al. Evolution of an adenocarcinoma in response to selection by targeted kinase inhibitors. Genome Biology. 11: R82. PMID 20696054 DOI: 10.1186/Gb-2010-11-8-R82 |
0.688 |
|
| 2010 |
Jones SJ, Laskin J, Li YY, Griffith OL, An J, Bilenky M, Butterfield YS, Chuah E, Corbett R, Fejes A, Chan S, Liao N, Kasaian K, Griffith M, Yee J, et al. Personalized oncogenomics Genome Biology. 11: I5. DOI: 10.1186/gb-2010-11-s1-i5 |
0.606 |
|
| 2010 |
Jones SJ, Laskin J, Li YY, Griffith OL, An J, Bilenky M, Butterfield YS, Cezard T, Chuah E, Corbett R, Fejes A, Griffith M, Yee J, Martin M, Mayo M, et al. Genomic analysis of a rare human tumor Bmc Bioinformatics. 11. DOI: 10.1186/1471-2105-11-S4-O3 |
0.683 |
|
| 2010 |
Morin RD, Mendez-Lago M, Mungall AJ, Johnson NA, Goya R, Severson T, Mungall K, An J, Yakovenko O, Jackman S, Krzywinski M, Griffith M, Chan S, Tam A, Smailus D, et al. Identification of Genes Frequently Mutated In FL and DLBCL with Transcriptome, Genome and Exome Sequencing Blood. 116: 804-804. DOI: 10.1182/Blood.V116.21.804.804 |
0.784 |
|
| 2009 |
Temple G, Gerhard DS, Rasooly R, Feingold EA, Good PJ, Robinson C, Mandich A, Derge JG, Lewis J, Shoaf D, Collins FS, Jang W, Wagner L, Shenmen CM, ... ... Griffith M, et al. The completion of the Mammalian Gene Collection (MGC). Genome Research. 19: 2324-33. PMID 19767417 DOI: 10.1101/Gr.095976.109 |
0.649 |
|
| 2008 |
Kuchenbauer F, Morin RD, Argiropoulos B, Petriv OI, Griffith M, Heuser M, Yung E, Piper J, Delaney A, Prabhu AL, Zhao Y, McDonald H, Zeng T, Hirst M, Hansen CL, et al. In-depth characterization of the microRNA transcriptome in a leukemia progression model. Genome Research. 18: 1787-97. PMID 18849523 DOI: 10.1101/Gr.077578.108 |
0.589 |
|
| 2008 |
Pugh TJ, Delaney AD, Farnoud N, Flibotte S, Griffith M, Li HI, Qian H, Farinha P, Gascoyne RD, Marra MA. Impact of whole genome amplification on analysis of copy number variants. Nucleic Acids Research. 36: e80. PMID 18559357 DOI: 10.1093/Nar/Gkn378 |
0.592 |
|
| 2008 |
Morin RD, O'Connor MD, Griffith M, Kuchenbauer F, Delaney A, Prabhu AL, Zhao Y, McDonald H, Zeng T, Hirst M, Eaves CJ, Marra MA. Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells. Genome Research. 18: 610-21. PMID 18285502 DOI: 10.1101/Gr.7179508 |
0.635 |
|
| 2008 |
Griffith M, Tang MJ, Griffith OL, Morin RD, Chan SY, Asano JK, Zeng T, Flibotte S, Ally A, Baross A, Hirst M, Jones SJM, Morin GB, Tai IT, Marra MA. ALEXA: A microarray design platform for alternative expression analysis [3] Nature Methods. 5: 118. PMID 18235430 DOI: 10.1038/Nmeth0208-118 |
0.595 |
|
| 2008 |
Griffith OL, Montgomery SB, Bernier B, Chu B, Kasaian K, Aerts S, Mahony S, Sleumer MC, Bilenky M, Haeussler M, Griffith M, Gallo SM, Giardine B, Hooghe B, Van Loo P, et al. ORegAnno: an open-access community-driven resource for regulatory annotation. Nucleic Acids Research. 36: D107-13. PMID 18006570 DOI: 10.1093/Nar/Gkm967 |
0.339 |
|
| 2008 |
Griffith M, Tang MJ, Chan S, Asano JK, Ally A, Pugh T, Tai IT, Marra MA. M1982 Identification of Differentially Expressed Alternative mRNA Isoforms Associated with Chemotherapy Resistance in Colon Cancer Cell Lines Gastroenterology. 134: A-444. DOI: 10.1016/S0016-5085(08)62075-2 |
0.602 |
|
| 2006 |
Bainbridge MN, Warren RL, Hirst M, Romanuik T, Zeng T, Go A, Delaney A, Griffith M, Hickenbotham M, Magrini V, Mardis ER, Sadar MD, Siddiqui AS, Marra MA, Jones SJ. Analysis of the prostate cancer cell line LNCaP transcriptome using a sequencing-by-synthesis approach. Bmc Genomics. 7: 246. PMID 17010196 DOI: 10.1186/1471-2164-7-246 |
0.512 |
|
| 2006 |
Morin RD, Chang E, Petrescu A, Liao N, Griffith M, Chow W, Kirkpatrick R, Butterfield YS, Young AC, Stott J, Barber S, Babakaiff R, Dickson MC, Matsuo C, Wong D, et al. Sequencing and analysis of 10,967 full-length cDNA clones from Xenopus laevis and Xenopus tropicalis reveals post-tetraploidization transcriptome remodeling. Genome Research. 16: 796-803. PMID 16672307 DOI: 10.1101/Gr.4871006 |
0.632 |
|
| 2004 |
Hirst M, Astell CR, Griffith M, Coughlin SM, Moksa M, Zeng T, Smailus DE, Holt RA, Jones S, Marra MA, Petric M, Krajden M, Lawrence D, Mak A, Chow R, et al. Novel avian influenza H7N3 strain outbreak, British Columbia. Emerging Infectious Diseases. 10: 2192-5. PMID 15663859 DOI: 10.3201/Eid1012.040743 |
0.413 |
|
| 2004 |
Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, ... ... Griffith M, et al. The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Research. 14: 2121-7. PMID 15489334 DOI: 10.1101/Gr.2596504 |
0.648 |
|
| 2004 |
Baross A, Butterfield YS, Coughlin SM, Zeng T, Griffith M, Griffith OL, Petrescu AS, Smailus DE, Khattra J, McDonald HL, McKay SJ, Moksa M, Holt RA, Marra MA. Systematic recovery and analysis of full-ORF human cDNA clones. Genome Research. 14: 2083-92. PMID 15489330 DOI: 10.1101/Gr.2473704 |
0.527 |
|
| Show low-probability matches. |